Navigation Links
Pharmos Corporation Reports 2007 Third Quarter Results
Date:10/30/2007

imately 480 female patients with diarrhea-predominant or alternating IBS at up to 55 participating U.S. centers over an 18-month period. Enrollment of patients in the study is currently on schedule.

Additional but relatively minimal research and development expenses were incurred during the quarter in connection with the Company's commencement in June 2007 of a Phase 2a clinical study of its topical NanoEmulsion drug delivery technology formulated with 3% diclofenac as a treatment for osteoarthritis. Up to eight centers in Israel will enroll a total of approximately 126 subjects over a nine-month period. Gross expenses for other research and development projects in early stages of development for the third quarter 2007 and 2006 were relatively unchanged at $0.9 million.

The decrease in general and administrative expenses is due primarily to lower professional fees and investor relations costs in connection with the Company's acquisition of Vela Pharmaceuticals, which was ongoing in the third quarter 2006 and completed by the fourth quarter 2006.

For the year-to-date period ended September 30, 2007, Pharmos recorded a net loss of $12.9 million, or $0.51 per share compared to a net loss of $11.3 million, or $0.60 per share in the same period in 2006. The increase in net loss is due to increased operating expenses and a decrease in net other income. Total operating expenses increased 7% to $13.7 million in the current year-to-date period from $12.8 million in the same period in 2006, primarily due to increased research and development expenses and lower grant receivables. Gross research and development expenses increased 41% to $9.3 million from $6.6 million, reflecting increased clinical trial-related activities. Grant receivables decreased to $0.8 million from $1.1 million in the same period in 2006. Higher research and development expenses were partially offset by a 29% decrease in general and administrative expenses to $5.0 million from $7.0 milli
'/>"/>

SOURCE Pharmos Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
11. Sonic Foundry reports GAAP loss as Q2 revenues rise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Aug. 19, 2014 CSSi, the leader in ... announced the formation of the company,s Medical and Clinical ... addition of Dr. William E. Gannon, Jr. ... The MCAB, with Dr. Gannon,s ... therapeutic areas and set strategic goals for the advancement ...
(Date:8/19/2014)... Scottsdale, AZ (PRWEB) August 19, 2014 ... the launch of its online sales skills training ... their sales skills. , MedTech clinical staff spend the ... at a hospital, standalone medical center, or physician practice ... administrative staff. But why stop there? Sales Horizons believes ...
(Date:8/18/2014)... FREDERICK, Md. , Aug. 18, 2014 ... the maker of advanced consumer medical devices ... Kotak was interviewed by CEOLIVE.TV as ... The entire interview is available at ... interview Dr. Kotak explains to investors the ...
(Date:8/18/2014)... According to a new ... Science Reagents Market(Products- PCR Reagent Kits, Cell and ... Reagents and Others; End Users- Commercial and Contract ... Forensic Laboratories)- Global Industry Analysis, Size, Share, Growth, ... life science reagents market was valued at USD ...
Breaking Biology Technology:CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 2Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 3BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 2Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 5
... (ZnO) are among the most technologically relevant semiconducting ... elements such as blue lasers (hence the blue-ray ... many uses in optoelectronics and sensors. In ... these materials have shown a plethora of potential ...
... SRI International, an independent nonprofit research and development ... by the Department of Energy (DOE) to expand its ... project will give SRI,s bioinformatics tools even greater utility ... derived from biological sources.   SRI will ...
... Jan. 26, 2011 Novel solutions to 21st century ... fourth annual executive education conference for female leaders in ... 2011. The Women Innovate Conference will feature ... business ranging from small start-ups to global corporations.  Together, ...
Cached Biology Technology:Nanowires exhibit giant piezoelectricity 2Nanowires exhibit giant piezoelectricity 3Department of Energy Funds SRI to Enhance Bioinformatics Tools for Renewable Energy Research 2Department of Energy Funds SRI to Enhance Bioinformatics Tools for Renewable Energy Research 3KGI Hosts Fourth Annual Conference for Women in Life Science Industry 2KGI Hosts Fourth Annual Conference for Women in Life Science Industry 3
(Date:8/20/2014)... 2014  The second annual Biometrics UnPlugged Executive ... Tampa, Florida on September 15, 2014, ... Technology and Strategy at Samsung, and Philippe de ... of this year,s event is Mobility at the ... "Biometrics UnPlugged: Mobility at the Crossroads of Commerce ...
(Date:8/19/2014)... 2014 To improve students, chances of completing ... University of Houston (UH) implemented a comprehensive student ... risk for failure. , Through a grant ... the Department of Biology and Biochemistry embarked on ... "General Biology" for non-majors and "Introductory Biology" for ...
(Date:8/19/2014)... in German . ... sources. If a large amount of electricity is to be ... will have to be stored during productive periods so that ... are far from adequate for the purpose. Science and industry ... lies on battery systems that used to be too expensive ...
Breaking Biology News(10 mins):Biometrics UnPlugged: Mobility at the Crossroads of Commerce & Privacy to Feature Interactive Sessions with Samsung and Experian 2University of Houson program earns kudos for improving grades, retaining students 2University of Houson program earns kudos for improving grades, retaining students 3Asian inventions dominate energy storage systems 2Asian inventions dominate energy storage systems 3
... Society of America presents a new Special Paper, Paleoenvironments ... This volume is the culmination of more than a decade ... long-lived Bear Lake, which is located 100 km northeast of ... the largest river in the Great Basin of the western ...
... remember Buckminster Fuller,s distinctive "geodesic domes" soccer-ball-shaped structures ... Tel Aviv University chemists remember them too and ... of multiple sclerosis (MS). In partnership with a ... Hospital at Harvard Medical School, Dr. Michael Gozin from ...
... and the Albert Einstein College of Medicine have ... (TB) and expose the deadly drug-resistant strains of ... strains. The researchers engineered bacteriophagestiny viruses that attack ... protein. They report their findings in the March ...
Cached Biology News:'Buckyballs' to treat multiple sclerosis 2Pitt-led researchers create quick, simple fluorescent detector for TB 2
... Extraction Software reads and processes ... prepare microarray data for analysis. ... one 1-year license for ... accounts ,one CD-ROM containing Feature ...
... Last innovation from Magnetofection technology, ... delivery system available. Simple, rapid and ... compatible and non toxic. Specifically designed ... gene silencing at very low doses ...
... handling system from Molecular Devices provides precise ... instrument. The system handles a variety of ... 384- and 1536-welland is the first to ... been optimized to dispense from four different ...
... Radiolabeled Ligands\n\nReceptor-related research has long been enabled ... ligands selected to keep pace with new ... products and services for receptor research and ... If you do not find exactly what ...
Biology Products: